Alanine glutamine dipeptide

Also known as: Alanine glutamine

Therapeutic indications

Alanine glutamine dipeptide is indicated for:

Hypercatabolic states, hypermetabolic states

Population group: both men and women, only adults (18 years old or older)

Alanyl glutamine is indicated as part of a clinical nutrition regimen in patients in hypercatabolic and/or hypermetabolic states. It should be given together with parenteral or enteral nutrition or a combination of both.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

0.3-0.5 g per kg body weight daily

Contraindications

Alanine glutamine dipeptide is contraindicated in the following cases:

Severe renal insufficiency (creatinine clearance <25 ml/minute)

at least one of

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Severe hepatic insufficiency

Hepatic failure stage IV

Severe metabolic acidosis

Metabolic acidosis

< Previous: Overview

Next: Precautions >